BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29611472)

  • 1. Inhibitors of Selected Bacterial Metalloenzymes.
    Žalubovskis R; Winum JY
    Curr Med Chem; 2019; 26(15):2690-2714. PubMed ID: 29611472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting metalloenzymes: a strategy that works.
    White RJ; Margolis PS; Trias J; Yuan Z
    Curr Opin Pharmacol; 2003 Oct; 3(5):502-7. PubMed ID: 14559095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP; Tan DT; Schenk G
    Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Review on Subclass B1 Metallo-β-lactamases Inhibitors: Sword for Antimicrobial Resistance.
    Kaushik A; Kaushik M; Lather V; Dua JS
    Curr Drug Targets; 2019; 20(7):756-762. PubMed ID: 30556502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Development of New Small-Molecule Inhibitors Targeting Bacterial Metallo-β-lactamases.
    Wang P; Cheng J; Liu CC; Tang K; Xu F; Yu Z; Yu B; Chang J
    Curr Top Med Chem; 2018; 18(10):834-843. PubMed ID: 29773066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?
    Oelschlaeger P; Ai N; Duprez KT; Welsh WJ; Toney JH
    J Med Chem; 2010 Apr; 53(8):3013-27. PubMed ID: 20121112
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacterial Zinc Metalloenzyme Inhibitors: Recent Advances and Future Perspectives.
    Di Leo R; Cuffaro D; Rossello A; Nuti E
    Molecules; 2023 May; 28(11):. PubMed ID: 37298854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual Screening Approach of Bacterial Peptide Deformylase Inhibitors Results in New Antibiotics.
    Merzoug A; Chikhi A; Bensegueni A; Boucherit H; Okay S
    Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28991412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking and antibacterial activity of novel nontoxic 5-arylidenepyrimidine-triones as inhibitors of NDM-1 and MetAP-1.
    Tumskiy RS; Tumskaia AV; Pylaev TE; Avdeeva ES; Evstigneeva SS
    Future Med Chem; 2021 Jun; 13(12):1041-1055. PubMed ID: 33913733
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
    Jain R; Chen D; White RJ; Patel DV; Yuan Z
    Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors.
    Salahuddin P; Kumar A; Khan AU
    Curr Protein Pept Sci; 2018; 19(2):130-144. PubMed ID: 28745223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Continuing Challenge of Metallo-β-Lactamase Inhibition: Mechanism Matters.
    Ju LC; Cheng Z; Fast W; Bonomo RA; Crowder MW
    Trends Pharmacol Sci; 2018 Jul; 39(7):635-647. PubMed ID: 29680579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling the Antibiotic Resistance Caused by Class A
    Eiamphungporn W; Schaduangrat N; Malik AA; Nantasenamat C
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.
    Chen AY; Thomas PW; Stewart AC; Bergstrom A; Cheng Z; Miller C; Bethel CR; Marshall SH; Credille CV; Riley CL; Page RC; Bonomo RA; Crowder MW; Tierney DL; Fast W; Cohen SM
    J Med Chem; 2017 Sep; 60(17):7267-7283. PubMed ID: 28809565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on β-lactamase inhibitor discovery and development.
    Docquier JD; Mangani S
    Drug Resist Updat; 2018 Jan; 36():13-29. PubMed ID: 29499835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents.
    Zhang J; Zhang L; Li X; Xu W
    Curr Med Chem; 2012; 19(13):2038-50. PubMed ID: 22414079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Process in the Inhibitors of UDP-3-O-(R-3-hydroxyacyl)-Nacetylglucosamine Deacetylase (LpxC) Against Gram-Negative Bacteria.
    Liu F; Ma S
    Mini Rev Med Chem; 2018; 18(4):310-323. PubMed ID: 27739357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Natural Product in Modulation of Drug Transporters and New Delhi Metallo-β Lactamases.
    Chandar B; Bhattacharya D
    Curr Top Med Chem; 2019; 19(10):874-885. PubMed ID: 30987566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
    Klingler FM; Wichelhaus TA; Frank D; Cuesta-Bernal J; El-Delik J; Müller HF; Sjuts H; Göttig S; Koenigs A; Pos KM; Pogoryelov D; Proschak E
    J Med Chem; 2015 Apr; 58(8):3626-30. PubMed ID: 25815530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii.
    Powers RA; Swanson HC; Taracila MA; Florek NW; Romagnoli C; Caselli E; Prati F; Bonomo RA; Wallar BJ
    Biochemistry; 2014 Dec; 53(48):7670-9. PubMed ID: 25380506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.